Briefs on local businesspeople, including Haitham Al-Beik, Catrina M. Lopes and Ashley Luongo.

Haitham Al-Beik of Marlborough is the CEO and one of the founders of Wings, an AI startup developing autonomous businesses.

Wings recently opened its local R&D lab in Littleton where the company will continue working on HiveRobotics, a unique collective of decentralized, self-organized robotic systems meant for the services industry. 

Al-Beik is also the founder of Let’s Butterfly, the parent incubator company that has developed the Wings brand.

 Al-Beik is an award-winning technologist and inventor. After moving from the United Arab Emirates to the United States, he earned a B.S. degree in electrical and computer engineering with distinction in 2005 from the Worcester Polytechnic Institute, and gained hands-on experience as a hardware, software, UI and sales engineer at various fast-growing companies.


Charles River Bank President and CEO Jack Hamilton recently announced that Catrina M. Lopes has been promoted to assistant controller.

Lopes joined Charles River Bank in January of 2016 as a teller. In March of 2018, she was promoted to marketing and sales coordinator. In her new role, Lopes will be performing accounting and finance functions, including financial reporting, account reconciliation, daily cash management, month end closing process, investments, fixed assets, accounts payable, wire transfers, and ensuring that the bank’s systems and processes are maintained in accordance with GAAP, under the direct supervision of the controller.

Lopes graduated with honors from the New England School of Financial Studies, a 2-year intensive program for emerging bank leaders. Lopes completed rigorous research projects related to many critical banking functions, including finance, asset-liability management, human resources, marketing and lending, concluding with a team project simulating management of an actual bank.

Currently, Lopes is enrolled in the D’Amore-McKim School of Business at Northeastern University in a dual degree program – Master in Business Administration (MBA) and Master of Science in Finance (MSIF). She expects to graduate in 2023 with concentrations in corporate finance and investments. Lopes earned a bachelor’s degree from the University of New England in Biddeford, Maine, in 2013. 

Charles River Bank is based in Medway.


Elevate Counseling Services, a practice serving the needs of clients from locations in South Easton, Middleborough and Bellingham, has promoted Ashley Luongo to assistant director of clinical operations.

Luongo previously held the position of associate administrative director of the practice’s Bellingham location.

In her expanded role, she will focus on growing the groups that Elevate Counseling is offering to its clients. She is working with CEO Leigh-Ann Larson on expanding the topics and numbers of groups that are available.

Luongo will continue with her other duties as well, which include overseeing the day-to-day operations of the practice’s Bellingham location, including administrative and training functions. She additionally maintains her own caseload of clients, with a concentration on high school teenagers.

Luongo joined Elevate Counseling Services in 2017 as a clinician. She previously worked in community mental health in Boston and on the South Shore, as well as in home therapy.

She earned her bachelor’s degree from Curry College and her master’s degree from Assumption College, and holds the LHMC (Licensed Mental Health Counselor) designation.

Elevate Counseling Services is a private group practice of behavioral health care professionals. 


Joseph De Vito, president and CEO of The Village Bank, has announced the promotions of Corey Rouleau and Elijah Hopkin as well as the hiring of Valdet Abazi.

Rouleau was promoted to vice president and treasurer in April. She joined The Village Bank in September 2009 as a staff accountant. In 2014, she was promoted to assistant treasurer/staff accountant, and in 2017 to assistant vice president/staff accountant. In 2019, Rouleau was promoted to assistant vice president/assistant controller.

In her new role, Rouleau will be responsible for overseeing the bank’s accounting operations and fiscal reporting, with a focus on establishing and meeting financial objectives.

She holds a bachelor’s degree in business administration from Nichols College and a master’s degree in finance from New England College of Business. She also earned a banking certification in finance and management from the Connecticut Bankers Association.

Hopkin was promoted to Waban branch manager in April. He was hired by The Village Bank in April 2015 and most recently held the position of assistant branch manager at the Auburndale branch office. Previously, he progressed from teller to senior teller to teller supervisor to senior customer service representative.

In his new role, Hopkin will foster new customer relationships, share responsibility for the daily branch operations and develop the team at the Waban branch office.

He holds degrees from BYU-Idaho and Longy School of Music of Bard College in Cambridge.

Abazi was hired as Newton Centre branch manager in March. He previously was an assistant branch manager for East Boston Savings Bank and also held positions at Belmont Savings/Peoples United and Brookline Bank/First Commons Bank.

Abazi will be responsible for the growth and success of The Village Bank’s newest branch office. The Kosovo native and Framingham resident holds a degree in management and informatics from the University of Pristina in Kosovo.

The Village Bank has eight full-service offices in Newton and Wayland and a loan center in Newton Upper Falls


Arch Therapeutics Inc., a Framingham-based developer of novel self-assembling wound care and biosurgical devices, has appointed Michael S. Abrams its chief financial officer.

In alignment with the company’s succession plan, Abrams joins Arch’s financial team in the role previously held by Richard Davis. Davis will remain with the company during a transition period, which will end on June 30, after which he will support the company in a consulting role through Dec. 31.

Abrams has more than 25 years of experience as a chief financial officer to numerous public and private companies; principal investor; investment banker; merchant banker; strategic and financial adviser; and board member. His capabilities span a broad range of activities with a particular expertise in the areas of operational management, complex financial engineering, financial advisory and capital markets strategy primarily for companies in the technology and healthcare sectors.

Abrams graduated with an MBA with honors from the Booth School of Business at the University of Chicago and received his BBA with honors from the University of Massachusetts at Amherst as a William F. Field Alumni scholar, an award given annually to the top finance student in the class.


DPS Group, a Framingham-based, privately owned global engineering, procurement, construction management and validation (EPCMV) firm serving high-tech process industries, today announced it has added Kara Goodwin as a senior proposal manager.

Reporting to Eddie Skillington, vice president of business development within the Group Project Operations in Boston, Goodwin will manage and execute the proposal lifecycle of all project opportunities. In this role, she will work closely with business development and operations staff to respond to proposals on behalf of the company’s Architectural & Engineering Design, Construction Management and Commissioning Qualification and Validation divisions. She will play an active role in the strategic planning of proposals and development of proposal content. She will inform and direct an operational approach to project pursuits and the delivery of best-in-class proposals with the goal of exceeding our clients’ expectations.

Goodwin brings more than nine years of experience in the A/E/C industry, previously working for construction management firms such as Commodore Builders and A/Z Corporation.

She holds a bachelor of arts degree in communications from Northeastern University and is a member of NAIOP’s Developing Leaders.


Adam Bokon of Natick has joined Rockland Trust as vice president, commercial loan officer for the bank’s Commercial Banking division in the Waltham office.

In his role, Bokon will be tasked with strengthening relationships with owners and managers of investment real estate companies throughout Greater Boston while focusing on lending opportunities for a wide range of investment properties, including multifamily, retail, office and industrial assets.

He has more than 15 years of experience working in the commercial banking sector, primarily in commercial real estate financing. Before joining Rockland Trust, he was a vice president of commercial real estate at Brookline Bank, and an assistant vice president of commercial real estate at People’s United Bank.

Bokon started his banking career at Wachovia Bank after receiving his undergraduate degree in business administration from the University of Connecticut. He also earned his MBA from the Australian Graduate School of Management at the University of New South Wales.

Bokon is a board member of the Real Estate Lenders Association and a member of the Real Estate Finance Association. 


Tech Advisors, a Medfield-based technology solution provider for small to mid-sized businesses, has appointed Catherine Kontogiannis help desk technician.

In this capacity, she works to support client requests for their IT needs.

Prior to recently joining Tech Advisors, Kontogiannis was a Dell field service technician, traveling locally to perform warranty repair work on laptops, desktops and servers.

She traces her fascination with technology and repairing things to her childhood in southern Arizona, recalling that her father brought home a computer, gave her a book on programming and urged her to figure it out. Later, after earning a bachelor’s degree from Barry University in Miami, Kontogiannis began her career, including teaching technology engineering for grades 5-12 in Dartmouth. She also taught students about coding. After completing a series of Cisco Network Academy courses and earning her CompTII A+ certification, she set out to pursue work in the field of IT.


RTN Federal Credit Union Board Volunteer William J “Bill” Croteau passed away on April 21.

A lifelong Amesbury resident, Croteau served as an RTN Board of Directors volunteer for 15 years, serving on the Asset Liability Management Committee, Legislation Committee and Supervisory Committee. He worked for GTE Sylvania in Exeter, New Hampshire, and Ipswich, a total of 33 years, retiring in 1992 at the age of 53.

RTN is a member-owned, not-for-profit financial cooperative based in Waltham.


Hebrew SeniorLife, the largest provider of senior health care and senior living communities in New England and an affiliate of Harvard Medical School, recently announced that Jennifer Derkazarian of Concord has joined the organization as chief quality officer.

The newly created role combines a wide range of risk management, safety and quality measurement functions with compliance, regulatory and improvement initiatives. Derkazarian joins Hebrew SeniorLife from Atrius Health, where she was chief nursing officer.

Derkazarian has overall accountability for quality, risk management and patient and resident safety programs in all Hebrew SeniorLife service areas, including Hebrew Rehabilitation Center Long-Term Chronic Care Services and Rehabilitation Services Units. She is also be responsible for the skilled nursing facility at Orchard Cove in Canton, NewBridge on the Charles Assisted Living in Dedham and outpatient clinics, home care and hospice in the Greater Boston area. She also has direct management and oversight responsibilities for Infection Control and Process Improvement. 

Prior to Atrius Health, where she worked for four years, Derkazarian served as director of Advanced Practice at Lahey Hospital and Medical Center. As a licensed provider, she also provided direct patient care for more than 15 years in cardiac electrophysiology and cardiac surgery.

A graduate of Union College with a bachelor of science degree in biology and history, Derkazarian earned several advanced degrees at MGH Institute of Health Professionals in Boston, including her R.N., M.S.N., N.P. and D.N.P.


The Clean Air Group LLC, commonly known as CR Clean Air, has selected Diego Tebaldi of Newton to fill the role of general manager.

Tebaldi joins CR Clean Air at a time when the company continues to grow fast and expand its market globally; his role will include overseeing the day-to-day operations of the firm, including recruiting additional talent, expanding the technical capabilities and client management and acquisition.

Prior to joining the CR Clean Air team, Tebaldi was at CECO Environmental, a publicly listed pollution control company, where he ran the HEE-Duall business, which included industrial air scrubbers and fans; as well as the Adwest business which included regenerative thermal oxidizers/RTOs. He has also been in leadership roles with firms in renewable energy and high-tech.  In addition to work in Boston, he has also been with firms in Geneva, Paris and London.

Tebaldi earned his bachelor’s degree from Buckingham University in the United Kingdom and is fluent in four languages: English, Italian, French and Spanish. He is a native of Italy,

CR Clean Air is a 60-year global provider of engineered solutions for air pollution control and environmental process compliance.


Allena Pharmaceuticals Inc., a Newton-based late-stage, biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney disorders, has appointed Dr. Richard D. Katz as chief financial officer (CFO).

Katz succeeds Edward Wholihan, whose planned departure was announced by the Company in November 2020.

Katz brings more than 20 years of experience in health care finance and corporate development to Allena. Most recently, he served as CFO at Liquidia Technologies Inc., a late-stage clinical biopharmaceutical company. Prior to Liquidia, he served as CFO at several biopharmaceutical companies, including Argos Therapeutics, Viamet Pharmaceuticals and Icagen Inc.

At Icagen, Katz played a key role in facilitating the company’s initial public offering and subsequent financings, the formation of several strategic collaborations and the company’s sale to Pfizer.

He began his career as a vice president in the health care investment banking group at Goldman, Sachs & Company, where he executed a broad range of transactions, including equity and debt financings, mergers and acquisitions and corporate restructurings.

He holds his B.A. from Harvard University, his M.D. from Stanford University School of Medicine and his M.B.A. from Harvard Business School.


AMAG Pharmaceuticals Inc. recently announced that its Board of Directors has appointed Scott Myers as AMAG’s president and CEO, and member of the board.

Myers succeeds William Heiden, who is stepping down from such roles in light of Myers’ appointment.

Myers brings nearly three decades of global pharmaceutical and medical technology experience to AMAG. He most recently served as chairman and CEO of Rainier Therapeutics, a clinical-stage biotechnology company focused on metastatic bladder cancer.

Prior to joining Rainier, Myers served as CEO, president and director of Cascadian Therapeutics Inc. He also served as CEO of Aerocrine AB, a medical device company, from 2011 to 2015. 

Myers is currently an independent director of Selecta Biosciences where he serves as chairman of the Compensation and Benefits Committee, as well as a member of the Nominating and Governance Committee. He also serves as an independent director for Harpoon Therapeutics, a clinical-stage biotechnology company where he serves on the Audit Committee.

Myers began his career in management consulting and then moved into the pharmaceutical industry through senior leadership roles at Johnson & Johnson, DOV Pharmaceuticals and UCB.

He holds a bachelor of arts degree in biology from Northwestern University in Evanston, Illinois, and an MBA from the University of Chicago Graduate School of Business.

Based in Waltham, AMAG is a pharmaceutical company focused on bringing innovative products to patients with unmet medical needs.


Activate Care, a provider of integrated health and social care solutions through a Screen-to-Intervene approach, continues on its path of growth and expansion with two new employees.

Josh Winslow of Natick has joined the growing team as vice president of engineering and Paul Micheli of River Forest, Illinois, as director of product management.

Winslow and Micheli’s work will support the company’s mission to connect patients, families, care teams and community partners to produce impactful results, addressing the growing needs of the nation, such as reducing homelessness, eliminating education inequalities, hunger, addressing mental health and much more.

As vice president of engineering, Winslow will help Activate Care grow and support the entire engineering department. He will develop and maintain a long-term engineering roadmap, and preserve and expand an engineering culture of innovation and excellence.

Winslow has over 10 years of experience as a leader in engineering and nearly 20 years of experience in the industry as a whole. In addition to that, he has almost 15 years of experience building software for medical research. 

As the director of product management, Micheli will create a product management practice that will focus on understanding the customer needs, defining product requirements and building solutions that will ensure care teams are properly caring for the health of their community.

He comes to Activate Care with nearly 20 years in user experience engineering in the healthcare technology space. Additionally, Micheli has years of product development background, having developed key healthcare products, such as anesthesia machines, a critical care ventilator, two electronic surveillance applications and care management software.


Brookline Bank has promoted Leslie Joannides-Burgos to executive vice president, division executive of the bank’s Retail & Business Banking Division.

Previously she was a senior vice president. In her role as executive president, Joannides-Burgos oversees a team of 220 colleagues across the bank’s retail banking delivery channel. Under her management are the bank’s branch network, its customer service center, as well as all business banking officers, financial advisers and mortgage originators.

Joannides-Burgos has more than 30 years of progressive banking management experience in the areas of sales, service, operations, colleague engagement and development. Her career includes positions where she managed multiple teams and direct reports, grew deposits, generated consumer and business loans and developed and maintained client relationships.

Joannides-Burgos has a bachelor of science degree from the University of Central Florida and completed the Graduate School of Banking program at ABA Stonier in Philadelphia. She is a board member of Operation Able, a nonprofit organization whose mission is to provide employment and training opportunities to job seekers from economically, racially and occupationally diverse backgrounds.

She resides in Franklin.


ERA Key Realty Services of Northbridge recently announced that Michael J. O’Brien, a veteran sports broadcaster and communications professional, has joined ERA Key as a Realtor in the Framingham office.

O’Brien, who has over 15 years of broadcast experience, has provided play-by-play for numerous colleges and universities throughout New England, including Bentley University in Waltham, Boston University, Merrimack College and Yale University. Prior to his return to Massachusetts, he was the radio and TV play-by-play broadcaster for the Wilkes-Barre/Scranton Penguins in Pennsylvania as well as the team’s director of Team Services and Media Relations.

He also served in the same roles for the Lowell Devils of the American Hockey League and their ECHL-affiliate, the Trenton Devils in New jersey. He began his career as executive assistant at the National Hockey League in New York City.

He earned his bachelor’s degree from Boston College. He currently serves as vice president of the Boston Chapter of Young Professionals of the American Cancer Society.


Virtusa Corp., a Southborough-based global provider of digital strategy, digital engineering, and IT services and solutions, recently announced Ashish Devalekar has joined the company as the managing director for Europe and the Middle East.

Devalekar recently served as head of financial services at Capgemini, UK and member of UK Country Board. Prior to that, he held leadership positions at Polaris, HCL and IBM Global Services. Over the past 20 years, he has helped organizations grow, innovate and transform by building diverse business and digital technology teams paired with his deep knowledge in the financial services and European marketplace, including managing Capgemini’s largest financial services client, according to Virtusa.

In his role at Virtusa, Devalekar will oversee a high-performing team across Europe and the Middle East that delivers business transformation, digital innovation, consulting, and IT services to strategic clients across banking, insurance, telecommunications, health care and life sciences, the company added in a press release.


Milford Regional Physician Group (MRPG) recently welcomed Dr. Geoffrey Stoker to its new orthopedics practice.

Stoker, a Massachusetts native, comes to MRPG from New England Baptist Hospital, where he completed a fellowship in hip and knee replacement. After completing his undergraduate studies at Boston College, he earned his medical degree from Washington University in St. Louis and completed his orthopedic residency at Tufts Medical Center, where he received the Henry Banks Outstanding Orthopedic Resident Award.

Stoker’s practice focuses on partial and total knee and hip replacement, including revision procedures. He evaluates and treats patients with a variety of hip and knee problems, such as arthritis, avascular necrosis, and other joint conditions. He has a special interest in preoperative optimization for medically complicated patients and enhanced recovery after surgery, including same-day, outpatient joint replacement.


North Easton Savings Bank has appointed Paul R. Little of Shrewsbury senior vice president, chief credit officer.

In this role, Little oversees commercial credit and collection policies, procedures and processes to measure and manage inherent risks in the Bank’s loan portfolio.

Little joins North Easton Savings Bank with 37 years of experience in the banking and commercial real estate industries, most recently as senior vice president, chief credit officer with the Savings Institute Bank & Trust Company/Berkshire Bank in Willimantic, Connecticut.

Little earned his bachelor’s degree in business administration from New England College and is a graduate of the American Community Bankers Senior Leadership Institute. He is a member of the Mortgage Bankers Association and the Society of Real Estate Appraisers.

North Easton Savings Bank has 18 eighteen local branches and over $1.1 billion in assets.


Reliant Medical Group, the locally based multi-specialty medical group, recently announce that Dr. Alexander Connaughton has joined the organization’s Department of Orthopedic Surgery.

Connaughton grew up in Wayland. He received his medical degree at Michigan State University in East Lansing, Michigan. He then completed his residency at Western Michigan University Homer Stryker M.D. School of Medicine in Kalamazoo, Michigan. He also completed a fellowship at The University of Buffalo Jacobs School of Medicine And Biomedical Sciences in Buffalo, New York, where he worked on the medical staff for the Buffalo Bills.

Connaughton is welcoming new patients at the Worcester Medical Center office at 123 Summer St. in Worcester as well as at 101 Cedar St. in Milford and 24 Newton St. in Southborough.


Affinia Therapeutics, a Waltham-based gene therapy company with a platform for rationally designed adeno-associated virus (AAV) vectors and gene therapies, has appointed Dr. Elliott Sigal to the company’s board of directors.

Sigal has more than 25 years of leadership experience in the biopharmaceutical industry and is the former chief scientific officer and president of R&D for Bristol Myers Squibb.

Sigal is a former member of the Board of Directors of Spark Therapeutics. During his tenure from 2014 to 2019, the company’s lead product, LUXTURNA, was approved as the first AAV gene therapy in the United States. The company was acquired by Roche in 2019.

Prior to Spark Therapeutics, Sigal was an executive vice president and director of Bristol Myers Squibb. While at BMS, he led the team that established BMS at the forefront of immuno-oncology which is revolutionizing the treatment of cancer and brought 14 new medicines to market for patients with devastating diseases in areas including oncology, hematology, cardiovascular disease, hepatitis, rheumatoid arthritis and neuropsychiatry. Sigal was instrumental in increasing R&D productivity and developing the company’s strategy in biologics. In 2012, he was named the best R&D chief in the pharmaceutical industry by Scrip Intelligence.

Sigal received his medical degree from the University of Chicago in 1981 and trained in internal medicine and pulmonary medicine at the University of California, San Francisco (UCSF). He also holds a bachelor of science, master of science and Ph.D. in industrial engineering from Purdue University. He currently serves as a senior adviser to the health care team of New Enterprise Associates and consults for select biotechnology companies including Amgen. He is co-chair of the Scientific Advisory Board of Amgen and is a member of the Scientific Steering Committee of the Sean Parker Institute for Cancer Immunotherapy. He is also a member of the Board of Directors for the biotechnology companies Adaptimmune and Surface Oncology.

Sigal joined BMS in 1997 and held roles in both discovery and development before ascending to chief scientific officer and president of R&D. Positions prior to BMS included a faculty appointment at UCSF, senior executive roles at Syntex/Roche and CEO of the genomics firm, Mercator Genetics.


Paytronix Systems Inc., a Newton-based developer of digital guest experience platforms, recently announced that Amy Porter, founder and executive chairman of Affinipay, a payments technology platform, has been appointed to the its board of directors.

Porter joins the board as Paytronix rolls out innovations in loyalty, order and delivery and stored value, aimed at helping the nation’s restaurant and convenience store brands find the additional value hidden within their own customer relationships.

Porter founded Affinipay in 2005 to build the preeminent payments technology company serving professional services businesses, according to Paytronix. As CEO, she spearheaded the Affinipay’s development of market-leading tools such as LawPay and CPACharge, which today are trusted to process over $6 billion annually on behalf of 150,000 professionals.

After bootstrapping Affinipay for its first 10 years, Porter chose Great Hill Partners as her first investment partner in 2015. By executing on Porter’s category-defining vision and prioritizing customer service, superior product and transaction security, Affinipay’s annual revenue grew by more than four times over the course of Great Hill Partners’ investment period, Paytronix added.

Affinipay is consistently ranked among the fastest growing companies in America by organizations, including Austin Business Journal and the Inc. 5000 list. Porter received the 2016 EY Entrepreneur Of The Year Award in the Financial Technology category for the Central Texas region. In 2019, she transitioned to become executive chairman of Affinipay. TA Associates acquired a majority of Affinipay in February 2020 with Great Hill exiting its investment.


AMAG Pharmaceuticals Inc. recently announced that Edward (Ted) Myles,  chief financial and chief operating officer, is leaving the company.

Brian Piekos, senior vice president of finance, has been appointed interim chief financial officer and will become a member of the company’s Executive Leadership Team. Anthony (Tony) Casciano has been appointed chief operating officer and will add significant operational responsibilities to his role in addition to leading commercial operations.

Piekos joined AMAG in 2015 and has held a number of senior management positions with the company. In his most recent role as senior vice president of finance, Piekos has provided oversight of AMAG’s financial planning and reporting, tax, treasury and strategic sourcing processes. He has more than 20 years of corporate finance experience, including strategic planning, financial reporting and capital market activities. Prior to AMAG, he held positions of increasing responsibility at Cubist Pharmaceuticals. Piekos began his career in investment banking having served as vice president at Leerink Partners and as an analyst at Needham & Company.

Casciano brings more than 20 years of commercial experience within the pharmaceutical industry. He joined AMAG in September 2016 and has since held positions of increasing responsibility with the company. In his role as chief operating officer, he will continue overseeing commercial activities, as well as technical operations, global supply chain and information technology for the company. Prior to AMAG, Casciano spent 16 years career at Sanofi, where he held multiple commercial leadership roles across a range of departments and therapeutic areas.

AMAG is a Waltham-based pharmaceutical company focused on bringing innovative products to patients with unmet medical needs.


Repligen Corp. has appointed health-care industry executive Carrie Eglinton Manner to its board of directors.

Eglinton Manner brings to the director role more than 23 years of leadership experience across multiple disciplines. She currently serves as senior vice president of advanced diagnostics at Quest Diagnostics, a provider of diagnostic information services, which she joined in 2017. Prior to Quest, Eglinton Manner held various roles of increasing scope and responsibility over a period of 20 years at GE Healthcare. From 2009 through 2016, she served as president and CEO of four distinct GE Healthcare global businesses in the areas of diagnostic imaging, lab services and medical devices, ranging in size from approximately $150 million to $3 billion in revenue.

In her role at Quest Diagnostics, Eglinton Manner is responsible for growing the company’s nearly $2 billion genetic and molecular diagnostics portfolio. Under her leadership, the advanced diagnostics portfolio has grown revenue and margin through innovation in specialty genetic offerings and services, productivity programs, key strategic alliances, and acquisitions. At GE Healthcare, Eglinton Manner also led improvements in financial performance and expanded the industry presence as president and CEO of Maternal Infant Care, Clarient Diagnostic Services Inc., Surgery, and Detection & Guidance Solutions.

In addition to joining the Repligen board, Eglinton Manner serves as board director for the not-for-profit Thrive Networks, where she retains a personal and professional commitment to advancing women and transforming health in underserved communities with reliable sanitation, water, and education. She holds a bachelor of science degree in mechanical engineering from the University of Notre Dame.

Repligen is a global life sciences company that develops and commercializes bioprocessing technologies and systems designed to increase efficiencies in the process of manufacturing biological drugs. We are inspiring advances in bioprocessing for the customers we serve; primarily biopharmaceutical drug developers and contract development and manufacturing organizations (CDMOs) worldwide.

With its corporate headquarters in Waltham, the company has additional administrative and manufacturing operations in Marlborough, Bridgewater, New Jersey,; Rancho Dominguez, California; Lund, Sweden; Breda, The Netherlands and Ravensburg, Germany.


Jewish Family Service (JFS) of Metrowest, a nonprofit, community-based organization that provides vital social, health and community services to alleviate suffering, enhance lives and support people in need, installed five new board members with three-year terms at the 2020 JFS Annual Meeting.

They are Stephanie Elkind of Newton, Elana Margolis of Sharon, Neil Ross of Wayland, Andrew Troop of Sudbury and Marissa Wainwright of Waltham.

The meeting also featured  the installation of officers and and the re-installation of board members with new terms.

The following officers were installed for two-year terms: New President Josef Volman of Newton, Vice-President Sari Rapkin of Needham, Treasurer John Herrera of Westport, Connecticut, New Vice-President Ian Rubin of Wayland, New Vice-President Jeffrey Swartz of Weston and New Secretary Ashley DePaolo of Ashland.

The following board members were reinstalled with the following terms: Chase Carpenter of Cambridge, term expiring 2023; Ari Freisinger of San Francisco, California, term expiring 2023; and Deborah Merkin of Wellesley, term expiring 2021.

In addition, attendees shared their appreciation for departing board members Chester Black of Wayland, Kevin Foley of Framingham, Penny Glassman, of Ashland, Robin Welch of Framingham and Michelle Wilen of Ashland. The meeting also provided an opportunity for the board to express its special thanks to departing president, David Milowe of Canton.

JFS is based in Framingham.


The Bar Method Wellesley barre studio has announced three new owners, two of them with long-established connections to Wellesley.

Under the legal name Studio Be-Wellesley, Courtney Sawicki, Neely Dodge and Rachel Stoff now own and operate the six-year-old fitness studio offering a variety of full-body exercise classes to clients of all levels. Dodge, Sawicki and Stoff are certified Bar Method instructors who have been employed at the Wellesley location and actively engaged with the clientele and staff in a variety of ways for multiple years.

Sawicki is one of the original instructors of The Bar Method Wellesley studio when it opened in 2014. She had discovered The Bar Method (TBM) in San Francisco in 2008 and loved its focus on small, targeted movements, safety and focus on form. Sawicki has been a French teacher for more than two decades. She grew up in Wellesley, where she and her husband reside with their two sons.

Hailing from South Carolina by way of New Hampshire, New York and New Jersey, Dodge began her love of TBM in Summit, New Jersey, where she was a client for more than a decade. TBM was the exercise that she was cleared to participate in after her third child was born. She became a Wellesley client in 2013 and an instructor since 2015. She has an IT and corporate background. Dodge has handled the retail management for the studio since 2018. She and her barre-practicing husband are active parents residing in Newton.

Growing up in Wellesley, Stoff was a dedicated ice skater and gymnast through high school. She introduced aerobics classes to her college campus, became trained in American Ninjutsu, taught kickboxing, spinning and mat Pilates on the side of demanding full-time careers in music and marketing over two decades in Los Angeles. She was a client of TBM West Hollywood, California. Shortly after relocating to her home state, she gravitated to the Wellesley studio (and reunited with childhood friend Sawicki). There, she immersed herself as a client, marketing consultant and instructor.


The Massachusetts Bankers Association (MBA) has elected new officers and members to its board of directors, including Patrick J. Murray, president and CEO of Bristol County Savings Bank in Taunton, as board chair.

The new officers and at-large MBA board positions include Mark R. O’Connell, president and CEO of Avidia Bank in Hudson, as treasurer.  The remainder of the Massachusetts Bankers Association Board of Directors includes Michael G. McAuliffe, president and CEO of Middlesex Savings Bank in Natick (re-appointment)


The Blackstone Valley Education Hub (BV Ed Hub) in Whitinsville has named Karen Ares executive administrator.

Ares will be responsible for day to day administrative operations and social media management of the school of advanced manufacturing.

Ares is a former high school science teacher who is passionate about STEM education. She holds a bachelor of science degree in biology from Eckerd College in St. Petersburg, Florida, and a master of science degree in occupational and environmental health and safety from Anna Maria College in Paxton.

Most recently, she was the assistant superintendent of teaching and learning and STEAM director for the Dudley Charlton Regional School District. During her time there, she acquired more than $600,000 in grant funding for various programs, most notably the Project Lead the Way STEM pathway for grades 6-12 in engineering and biomedical science. She also led the charge for Shepherd Hill Regional High School to become one of 11 high schools in Massachusetts to acquire Innovation Pathway designation in 2019.

She resides in Northborough.

The Blackstone Valley Chamber of Commerce (BVCC) developed the BV Ed Hub as a partnership between local secondary and post-secondary education providers and manufacturers to create sustainable work-based learning and vocational training in advanced manufacturing to meet work place demands.


Advantage Truck Group vice president of fleet sales Steve Gustafson has been named by Freightliner Trucks as a Leland James Elite award recipient as one of the top 32 sales professionals in North America for 2019 recognized for sales excellence, customer service and industry leadership.

Gustafson, who has worked at Advantage Truck Group’s Shrewsbury location for more than 20 years, has earned this distinction 14 times since Freightliner first presented its sales achievement award in 2004.

Established in 2003 and named in honor of Freightliner Trucks’ founder, the Leland James Elite Sales Achievement program recognizes and rewards outstanding sales representatives and managers in the Freightliner dealer network throughout the United States and Canada.


Ryan Gagne, owner of Venture X, a boutique, hotel-style co-working and flexible office space in Marlborough, was recently honored by the Marlborough Regional Chamber of Commerce as its 2020 “Business Person of the Year.”

The annual award is presented to an individual who has made an impact in the region’s business community and recognizes him/her for giving back through leadership by example.


Danforth Advisors LLC, a life science industry’s resource for operational accounting, finance support and strategic CFO advisory, has appointed Dr. Stephen J. Hoffman to its board of directors and to a senior advisory role for the firm’s clients.

An accomplished life science entrepreneur, executive and investor, he brings three decades of knowledge and influential relationships to his position as a strategic thought partner to scientific founders and CEOs navigating all stages of corporate evolution, according to Danforth. His initial focus will be assistance with fundraising for earlier stage companies.

Hoffman’s expertise lies in building life science companies and leading entrepreneurial teams to create shareholder value. He helped found two public companies, Somatogen Inc. and Allos Therapeutics Inc. – where he spent nearly nine years as CEO and another ten as chairman until the company’s acquisition by Spectrum Pharmaceuticals, Inc.

He has served on the boards of 18 life science companies, both public and private, with four posts as chairman and extensive committee experience. On the venture capital side, he has over 15 years of experience leading private equity investments totaling more than $140 million. As managing director at Skyline Ventures and general partner at TVM Capital, he played a major role in portfolio company development, guiding corporate strategy and business development, private and public financings, and clinical and regulatory strategies. He was twice named among the Top Advisors in US Healthcare/Venture Capital by Day & Associates.

He holds an M.D. from the University of Colorado School of Medicine and Ph.D. in chemistry from Northwestern University. He completed a fellowship in clinical oncology and a residency and fellowship in dermatology at the University of Colorado.

Danforth Advisors in based in Waltham.


John A. LeBlanc, of Milford, staff vice president and senior engineering technical specialist at FM Global, a Johnston, Rhode Island-based commercial property insurer, has received the 2020 Special Achievement Award from the National Fire Protection Association. The award acknowledges LeBlanc for his many years of service to the organization in contributing to the development of national fire codes and standards designed to protect commercial and industrial properties.

LeBlanc, a world recognized fire protection expert, has worked for FM Global for 35 years in a wide variety of loss-prevention engineering and consulting roles. He serves on ten NFPA technical committees related to explosion protection systems, aerosol products and flammable liquids, to name a few.

LeBlanc is a member of the American Institute of Chemical Engineers and the Society of Fire Protection Engineers. He holds a bachelor’s degree in chemical engineering from Case Western Reserve University in Cleveland, Ohio, and a master’s degree in fire protection engineering from Worcester Polytechnic Institute.


Eloxx Pharmaceuticals Inc., a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel therapeutics to treat cystic fibrosis and other diseases caused by nonsense mutations limiting production of functional proteins, recently announced that Professor Eitan Kerem, M.D. has joined the company as a senior consultant.

Kerem will continue to advise on Eloxx’s cystic fibrosis program focusing on strategic leadership, cystic fibrosis medical safety review, and medical communications, as well as liaising with patient advocacy groups and regulatory authorities.

Kerem joined Eloxx on Sept. 1 upon his retirement from Hadassah Medical Center where he most recently served as head of pediatrics and professor of pediatrics at Hebrew University Hadassah Medical School. He was a board member of the European Cystic Fibrosis Society where he contributed to the development of the European Cystic Fibrosis Registry and was the president of CIPP, the annual International Congress on Pediatric Pulmonology. Kerem was previously a member of the editorial boards of the leading journals in the field of pulmonology, “Pediatric Pulmonology,” “Chest” and the “American Journal of Respiratory and Critical Care Medicine.”

Kerem has been intimately involved with ELX-02 and the Eloxx team since 2015, originally working with Professor Timor Baasov at the Technion Institute to optimize ELX-02 in the early stages of its development. He is a globally renowned cystic fibrosis Key Opinion Leader and has helped guide Eloxx through the development of the company’s clinical trial program. He serves on the company’s Cystic Fibrosis Medical Advisory Board, has been the Global Lead Investigator for our Phase 2 cystic fibrosis clinical trial program and had served as chairman of the Safety Review Committee.

Eloxx is based in Waltham.


Radius Health Inc. recently announced that Jose (Pepe) Carmona will be stepping down as its chief financial officer.

Dan Dolan, who has served as head of Financial Planning and Analysis since he joined the company in 2017, will become the principal financial and accounting officer. Dolan was instrumental in the launch of TYMLOS and works closely with all of the business functions within the company. In this role, he will report directly to Radius CEO Kelly Martin.

Jim Chopas, currently the company’s controller, will continue in that role with oversight of all finance functions including accounting, audit, tax, and treasury. Chopas has been with Radius since 2018 and will also report directly to Martin.

Based in Waltham, Radius is a science-driven fully integrated biopharmaceutical company committed to developing and commercializing innovative endocrine therapeutics.


Matthew Maher recently joined Berkshire Hathaway HomeServices Page Realty as assistant marketing director.

The announcement was made by Ellen Rao, broker/owner of Berkshire Hathaway HomeServices Page Realty.

Maher will be responsible for providing impactful marketing assistance and support to the brokerage and agents. Prior to joining Berkshire Hathaway HomeServices Page Realty, he was marketing director for ERA Cape Cod Real Estate for 5 years.

Berkshire Hathaway HomeServices Page Realty is a full-service real estate company specializing in residential sales since 1963. The company has offices in Medway and Medfield.


Berkshire Hathaway HomeServices Page Realty recently announced that Laurie Henighan has completed the real estate industry’s most comprehensive new home sales course to earn her national certification as a Certified New Home Specialist.

With this certification, Henighan  joins a group dedicated to providing the highest level of professionalism and service to builders and new home buyers.

Henighan is active in real estate sales and is licensed in both Massachusetts and Rhode Island. She also holds the Residential Construction Certified designation.

Berkshire Hathaway HomeServices Page Realty is a full-service real estate company specializing in residential sales since 1963. The company has offices in Medway and Medfield.


Mirick O’Connell recently announced that Brian R. Falk of Milford has been admitted to the partnership.

Falk is a member of the firm’s Public and Municipal Law Group and the Real Estate and Environmental Law Group. He also leads Mirick O’Connell’s Cannabis Industry Group.

Falk counsels towns, cities and districts in all areas of municipal law, including zoning, real estate, town meeting procedure, elections, procurement, open meetings, ethics and general governance. He also represents private clients in local land use permitting matters. He regularly appears before municipal boards seeking special permits, variances, licenses, zoning amendments and other approvals for large projects and challenging sites.

Falk shares in the firm’s commitment to the community and is currently serving on the board of the Milford Area Chamber of Commerce. He is an active member of the Worcester County Bar Association and serves on its Government Relations Committee. In addition, Falk has been named a Massachusetts “Rising Star” by Boston magazine and Law & Politics.

Mirick O’Connell is a full-service business law firm with offices in Worcester, Westborough and Boston.


Kristen Berger of Marlborough recently received the 2020 Dexter Brackett Memorial Award from the New England Water Works Association (NEWWA), the region’s largest and oldest not-for-profit organization of water works professionals.

The Dexter Brackett Award was established in 1916 in honor of an early prominent member of NEWWA. The award is presented annually to the member of the association who authored the most meritorious paper published in the Journal of the New England Water Works Association during the previous year.

Berger received this award for her paper “Dynamic Hydraulic Modelling for Water Systems,” which was published in the Journal of the New England Water Works Association Vol. CXXXIII, No. 1, March 2019. She has previously authored several other papers for the Journal.

Berger is a civil engineer with approximately 20 years of experience specializing in municipal infrastructure with a focus on drinking water supply, treatment and distribution. She founded Resilient Civil Engineering P.C. in 2019 with the goal to provide responsive, authentic, customized service with a focus on client satisfaction.

Berger is a current member of the NEWWA Program Committee. She is also a member of the American Water Works Association, the Massachusetts Water Works Association, and the Barnstable County Water Utilities Association. She is a past recipient of the NEWWA Past Presidents Award for the second most meritorious authored paper that appeared in the Journal of the New England Water Works Association, a past recipient of the NEWWA Younger Member of the Year Award and a previous winner of the Fresh Ideas Competition for the Connecticut Section of the American Water Works Association.

She holds a bachelor of science degree in civil engineering and a master of science degree in environmental engineering from the University of Massachusetts Amherst.

The New England Water Works Association is based in Holliston.


Allena Pharmaceuticals Inc., a late-stage, biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney disorders, has appointed Dr. Ann Miller to its board of directors.

Miller has launched and grown multiple blockbuster products and built leading franchises over the course of her career. Most recently, she spent six years at Sanofi, ultimately serving as vice president of marketing, where she was selected to lead a corporate-wide initiative on marketing excellence.

Prior to Sanofi, Miller spent two years as senior vice president at Eisai, where she led the Pharmaceutical Services and Primary Care and Specialty Business units, including the blockbuster franchises Aricept and Aciphex. Earlier in her career, she worked at Amgen, where she contributed to building the global marketing function, including serving as executive director of North American commercial operations and executive director of global marketing, and provided commercialization and life cycle management oversight for key products, including Neulasta and Vectibix.

Before that, Miller spent 16 years at Merck & Co., where she held a series of roles of increasing responsibility, including brand leadership for Fosamax, Mevacor and Zocor. She currently serves on the board of Inovio Pharmaceuticals and Puma Biotechnology. She holds both her B.A., with honors, and her M.D. from Duke University.

In conjunction with Miller’s appointment, Allena announced that founding board member Dr. Bob Tepper, a partner at Third Rock Ventures and founding member of the company’s board of directors since 2011, has resigned from the Allena noard.

Allena is based in Newton.


Radius Health Inc. recently announced that Peter A. Schwartzman is joining the company as vice president in the newly formed Capital, Strategy and Transactions (CST) Group.

Schwartzman, as part of the group, will report to Kelly Martin, CEO of Radius.

The CST group is responsible for the analysis and due diligence required for all business development activities and acts as the company’s point of contact for capital providers, investment banks and analysts. The CST group is also responsible for building the financial model framework the company will use to assess current and future performance.

Schwartzman joins Radius from Piney Lake Capital Management LP where he was a senior member of the investment team. At Piney Lake, he focused on opportunistic debt and equity investments in small to medium-sized companies in the health care, life sciences and industrial sectors.

For two decades prior, Schwartzman was a managing director in the Leveraged Finance Group at BlackRock Inc. In this role, he led the group’s investments in the health care, life sciences, media and gaming industries. He has also worked at Alliance Capital in its Corporate Bond Research Group as well as the HealthCare Group at Moody’s Investor Services.

Schwartzman earned his B.A. degree from Trinity College in Hartford, Connecticut, and his MBA from the Stern School at New York University.

Based in Waltham, Radius is a science-driven fully integrated biopharmaceutical company that is committed to developing and commercializing innovative endocrine therapeutics.


Digital Guardian, a Waltham-based provider of data loss prevention and managed detection and response, recently announced that Tim Bandos will become its chief information security officer (CISO).

Bandos will bring more than 15 years of experience to the position, including his five years as vice president of cybersecurity at Digital Guardian. Prior to joining Digital Guardian, Bandos was director of cybersecurity for Dupont where he was responsible for overseeing internal controls, incident response and threat intelligence. In his new role, he will lead Digital Guardian’s global cybersecurity strategy, leveraging the latest technology and threat intelligence available.

Bandos joined Digital Guardian five years ago with the goal of successfully building the company’s Managed Detection & Response Service from the ground up. That service now manages and monitors more than one million endpoints and delivers best-of-breed threat hunting and incident response.


ReWalk Robotics Ltd. has appointed Randel Richner to its board of directors.

Richner’s extensive history experience in health policy, reimbursement, economics and data analytics includes serving as the industry representative on the Centers for Medicare & Medicaid Services’  Medicare Coverage Advisory Committee; service on the Executive Dean’s Advisory Board at the University of Michigan’s School of Public Health; establishing the global reimbursement and economics function at Boston Scientific as that organization’s vice president of Global Government Affairs and Reimbursement and in founding Neocure, a firm that advised industry on health care policy.

Richner received a master of public health degree in health policy and administration and a bachelor of science degree in nursing from the University of Michigan in Ann Arbor, Michigan.

ReWalk Robotics develops, manufactures and markets wearable robotic exoskeletons for individuals with lower limb disabilities as a result of spinal cord injury or stroke. ReWalk has headquarters in the Marlborough, Israel and Germany.


Synspira Therapeutics, a clinical-stage biopharmaceutical company dedicated to improving the lives of people with cystic fibrosis (CF) and other rare diseases, has appointed Dr. Drucy Borowitz to its board of directors.

Borowitz is a global leader in clinical research and patient care for cystic fibrosis (CF) with particular expertise in gastrointestinal disease and nutrition. The company also announced that current board member, Alexey Margolin, will take on an expanded role as chairperson of the board of directors.

Borowitz is the former senior vice president of community partnerships at the Cystic Fibrosis Foundation where she led numerous initiatives to improve patient care and advance new Treatments.

She was the CF center director at the Women and Children’s Hospital of Buffalo for almost 20 years. In 2013, she received the Richard C. Talamo Distinguished Clinical Achievement Award presented by the Cystic Fibrosis Foundation to individuals dedicated to the research and care of patients with cystic fibrosis and whose contributions have had considerable influence on the course of the disease.

Borowitz is an emeritus professor of clinical pediatrics at the Jacobs School of Medicine and Biomedical Sciences of the University at Buffalo. She received the Stockton Kimball Award, bestowed on faculty members who have achieved worldwide recognition as researchers and have been recognized for significant academic accomplishment and service to the university. She attended Cornell Medical School, interned at Children’s Hospital of Philadelphia, and did her residency at University of California-San Francisco. She was board certified in pediatric gastroenterology and nutrition.

Margolin, who joined the company’s board in October 2019, is chair of the board of Allena Pharmaceuticals, a public clinical stage pharmaceutical company he co-founded, and previously served as CEO (2011-2019). Prior, he co-founded Alcresta Therapeutics, a medical device company focused on developing products for CF and other rare diseases; he served as CEO (2011-2014) and is currently on the board of directors. In 2008, Margolin co-founded Alnara Pharmaceuticals, and served as president and CEO until 2010, when the company was acquired by Eli Lilly. As chief scientific officer for Altus Pharmaceuticals, he helped build a portfolio of products for rare diseases. Margolin is the author of more than 60 publications and an inventor on numerous patents.

Synspira is a privately held company headquartered in Framingham.


Doc Wayne Youth Services, a Boston nonprofit that fuses sport and therapy to heal and strengthen at-risk youth, recently announced that Dr. Sadé Callwood, Katherine Grover and Dushawne “Doc” Simpson have recently joined its board. Their appointments further enhance the board’s experience, diversity and skills, and bring the number of members to 13.

Callwood is a post-doctoral fellow and psychotherapist at Commonwealth Psychology in Boston. Her clinical work with historically marginalized and oppressed individuals is influenced by her Caribbean-American upbringing. She earned her doctor of psychology in clinical psychology degree with an emphasis in African and Caribbean mental health from William James College and completed her doctoral project on Young Black Men’s Experiences of Aggressive Policing. She has extensive training in counseling centers within small private colleges, Ivy League and Big Ten universities.

A Framingham resident, Grover is a director in the Northeast Health Industries Assurance practice at PricewaterhouseCoopers in Boston, working with higher education, health care and other not-for-profit organizations. She is a Uniform Guidance expert and speaker, and a contributing author to Perspectives in Higher Education. She earned her bachelor’s degree in business administration from Babson College in Wellesley and her master in business administration degree with a concentration in not-for-profit management from Suffolk University.

Simpson is currently the head coach of The Pingree School’s girls varsity soccer team and the director of coaching at NEFC North Shore, and the former assistant coach of the Boston Breakers professional team. He began coaching for Pingree in 2011, and led them to New England championships in both 2013 and 2014. Dushawne was not only a standout soccer player growing up in Connecticut, he was selected to the 1990 CT All-State team in soccer, basketball and track. Following his exceptional playing at Southern Connecticut State University and Salem State College, he went on to play professionally for several teams, including the New Hampshire Phantoms, Connecticut Wolves and Boston Bulldogs.


RE/MAX LLC has recognized Gary Kelley with its RE/MAX Hall of Fame Award.

This recognition is bestowed on only 20% of agents, and recognizes the highest levels of expertise and a commitment to exemplary client service. With a focus on guiding clients through major life transformations, and supporting them at every step of the process, Kelley and his team have developed a loyal following and an unmatched network of word-of-mouth referrals, according to RE/MAX. The Hall of Fame award builds upon and recognizes his team’s hard work and deep knowledge.

Kelley and his colleague Sue Gordon work with buyers and sellers throughout the Marlborough, Westborough and Southborough areas.

RE/MAX Executive Realty is one of the largest real estate companies in Metrowest and the largest RE/MAX franchise in New England. It has offices in Framingham, Franklin, Holliston, Hopkinton, Marlborough, Medfield and Grafton.


Family law firm Barach Law Group LLC recently announced that attorneys Matthew Barach and Jennifer Salerno were selected for inclusion on the list of 2020 Massachusetts Super Lawyers.

Barach was named to the Super Lawyers list and Salerno was recognized as a Rising Star, a distinction for candidates who are either 40 years old or younger or who have been in practice for 10 years or fewer. The results were published in Boston Magazine and in New England Super Lawyers, which is published by Thomson Reuters.

Barach is the founder and principal of Barach Law Group and author of “The Family Law Guide to Appellate Practice.” With over 20 years of family law experience, Barach regularly appears before Middlesex, Norfolk, Worcester, Suffolk and Essex County Family Law Courts. He also appears before the Massachusetts Appeals Court, the Massachusetts Supreme Judicial Court and the First Circuit of Appeals.

Salerno is a senior associate at Barach Law Group focusing her practice on all areas of family law, including high conflict divorce and highly contentious child custody matters. She has successfully litigated child removal requests and international child abduction cases in the Probate and Family Courts and U.S. District Court in Boston. Prior to her joining Barach Law Group, Salerno was associated with a Boston-based firm where she specialized in family law.

Super Lawyers is a rating service of outstanding lawyers from more than 70 practice areas, who have attained a high degree of peer recognition and professional achievement. The patented multiphase selection process is designed to create a credible, comprehensive and diverse listing of outstanding attorneys that can be used as a resource for attorneys and consumers searching for legal counsel.

Barach Law Group LLC is based in Framingham.


4D Path, a Newton-based creator of a patented computer-aided cancer diagnostic and precision oncology platform, recently announced that Dr. Jennifer Levin Carter has joined the company’s advisory board.

Carter is managing director of JLC Precision Health Strategies LLC., which partners with executives and investors to advise data-driven healthcare and life science companies on their commercial and financing strategy, and on the development of novel products and services.

Previously, she was founder and CEO of TrialzOWN Inc., a healthcare company in stealth that was acquired by Integral Health (now Valo Health) in March 2019. Prior to TrialzOWN, Carter was the founder and president of N-of-One Inc. At N-of-One, she led the creation of award-winning solutions that delivered novel treatment strategies to hundreds of thousands of patients with cancer globally. She served as acting CEO from 2008-2012, and chief medical officer from 2012 until its acquisition by Qiagen (Market Cap $8B) in 2019.

Carter graduated Phi Beta Kappa, Summa Cum Laude with distinction with a BS in Molecular Biophysics and Biochemistry from Yale University, an MD from Harvard Medical School, an MPH from Harvard School of Public Health, and an MBA from the Sloan School at Massachusetts Institute of Technology.


Susan C. Stevenson of Ashland, has joined as a new member of the McDaniel College Board of Trustees.

Stevenson is a 1985 alumna of McDaniel (formerly Western Maryland) College with a bachelor’s degree in chemistry and a minor in biology. She played on cross country, lacrosse, outdoor track, and intramural sports teams as well as served as a member of Phi Alpha Mu sorority and the Beta Beta Beta Biology Honor Society.

Stevenson is an executive director in the Exploratory Disease Area (DAx) in the Chemical Biology and Therapeutics Department at the Novartis Institutes for Biomedical Research (NIBR) in Cambridge.

With more than 30 years of experience in drug discovery in the development of multiple therapeutic modalities, Stevenson prioritizes mentoring to support the next generation of scientific leaders within Novartis as well as in the larger scientific community. She supports diversity and inclusion initiatives and employee resource groups focused on developing cross-cultural awareness and advancing women in leadership positions.

In 2016, Stevenson was honored as a Novartis Leading Scientist in recognition of her leadership, innovation, and research excellence. Stevenson earned a Ph.D. in biochemistry from Wake Forest University in Winston-Salem, N.C., followed by a post-doctoral fellowship at Columbia University in New York. At McDaniel, she will serve as a member of the academic and campus life and audit and risk committees.


Psychemedics Corporation recently announced that Sarah Ashby has rejoined the company as vice president, general counsel.

In this role, Ashby will be responsible for directing and managing all of the company’s legal activities. She will report directly to the company’s CEO.

Sarah rejoins Psychemedics from Decibel Therapeutics Inc., a biotech start-up researching hearing loss therapeutics, and Takeda Pharmaceutical Company Ltd.  In the past four years, she has worked closely with the R&D teams at those organizations in the areas of toxicology studies, clinical trials, research collaborations and contract negotiations.

Previously, Ashby practiced law at the Boston firms of Campbell Campbell Edwards & Conroy PC, and Wilmer Cutler Pickering Hale & Dorr LLP. Her litigation background includes pharmaceutical and medical device liability, as well as health care fraud investigations, FDA regulation and intellectual property.

Based in Acton, Psychemedics Corporation is the world’s largest provider of hair testing for the detection of drugs of abuse. 


Sunstein LLP recently announced the addition of attorney John W. Powell of Hopkinton as a partner in the firm’s Patent Practice Group.

Powell brings extensive legal, technology and business experience to the firm gained in more than two decades of in-house and law firm practice.  As in-house counsel he served as vice president, general counsel and secretary of American Superconductor Corporation (AMSC), a publicly traded global energy technologies company focused on the renewable energy and electric grid markets, and as IP counsel at Raytheon and Motorola. Most recently he was a partner at the Boston law firm Verrill Dana LLP.

Powell received his JD from the University of New Hampshire School of Law and is a member of the Massachusetts Bar.

Sunstein LLP is a boutique intellectual property law firm.


The Bulfinch Group recently announced that Peter Klay, of Ashland, has earned the designation of Five Star Investment Professional.

The Five Star Financial Investment Professional award is annually given to financial services professionals who are identified through research conducted with peers and firms; the program analyzes internal and external research data.

Nominated financial services professionals who satisfied a total of ten objective eligibility and evaluation criteria, e.g., years of experience, client satisfaction and academic achievement, are awarded this prestigious title. 


The Bulfinch Group recently announced that Gary Peters, of Weston, has earned the designation of Five Star Wealth Manager.

The Five Star Wealth Manager award is annually given to financial managers who are identified through research conducted with peers and firms; the program analyzes internal and external research data, including a survey to more than 3,000 registered financial services professionals and all local financial service companies registered with FINRA or the SEC, to select each year’s winners.

Nominated wealth managers who satisfied a total of ten objective eligibility and evaluation criteria are awarded this prestigious title.


The Bulfinch Group recently announced that Kevin S. Schneider, of Marlborough, has earned the designation of Five Star Wealth Manager.

The Five Star Wealth Manager award is annually given to financial managers who are identified through research conducted with peers and firms; the program analyzes internal and external research data, including a survey to more than 3,000 registered financial services professionals and all local financial service companies registered with FINRA or the SEC, to select each year’s winners.

Nominated wealth managers who satisfied a total of ten objective eligibility and evaluation criteria are awarded this prestigious title. Schneider attended Colby College.


Colantonio Inc. recently welcomed Assistant Project Managers Ashley Gilmore and Steven Guntharp to the team.

Gilmore, who holds a B.S. degree in interior design from the New England Institute of Art, brings eight years of industry experience as an assistant project manager and project coordinator, specializing in renovation work on large college campuses and in high-rise buildings in Boston and Cambridge.

She is currently working on McCormack Building Immediate Needs, a comprehensive systems upgrade project at the Division of Capital Asset Management and Maintenance’s headquarters in Boston. 

Guntharp’s eight years of experience as an assistant project manager, framer and drywaller also includes renovation work on college campuses. He holds an M.S. degree in construction management from New England Institute of Technology and a B.S. degree in marketing from Salve Regina University.

Guntharp served four years in the U.S. Coast Guard in the Deck Department as a firefighter, weapons petty officer, cutter surface swimmer, rescue and survival petty officer and damage control expert. At Colantonio, he is assigned to the Roosevelt Towers Low-Rise Modernization project for the Cambridge Housing Authority.

Colantonio Inc. is a Holliston-based construction management and general contracting firm with self-performance capabilities.


Dr. Robert Cardales-Stearns has joined the team at Natick Family Dental.

As a general dentist specializing in cosmetic and sleep dentistry, Cardales-Stearns draws on five years of experience.

He majored in biology at the University of Georgia and received his Doctor of Dental Medicine degree (DMD) from Boston University School of Dental Medicine.


Dyne Therapeutics Inc., a Waltham-based muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, has appointed Dr. Ashish Dugar senior vice president, global head of medical affairs.

Dugar brings over 20 years of broad experience across medical affairs, clinical and commercial development and real-world evidence (RWE) generation.

Prior to joining Dyne, Dugar served as vice president and global head of medical affairs at Sarepta Therapeutics Inc., where he built the company’s medical affairs organization. Previously, he led all commercial and market access efforts for Intra-Cellular Therapies, Inc. as vice president and head of commercial development. He joined Intra-Cellular Therapies following his tenure at Roche, where he was global head of clinical development science and innovation and global head of the external development group, including work in oligonucleotides.

Previously, Dugar spent 13 years at Pfizer Inc. in various roles, most recently serving as vice president, global head of clinical development and medical affairs of the biosimilars business unit.

He began his career at the National Institutes of Health. He completed a pharmacoeconomics and outcomes research fellowship at the University of Michigan School of Public Health.

Dugar earned an MBA from The Pennsylvania State University and a Ph.D. in pharmacology from The Pennsylvania State University College of Medicine.


Special Needs Law Group of Massachusetts, a Framingham-based law firm specializing in estate and special needs planning, special needs trust administration, guardianship and transition planning, has welcomed Phyllis Jones as its newest attorney. 

Jones joins the practice with more than 20 years of legal experience.  Her career has included the following areas of law: family law, estate planning, immigration, school disability law, labor and employment law, corporate litigation, bankruptcy litigation, workers’ compensation and collections law.  

Jones brings her strong advocacy skills to the practice along with her representation in a number of professional organizations, including the Women’s Bar Foundation and Massachusetts Special Education Attorneys Egroup. She has served as chair of the North Andover Commission on Ability Assistance for over four years.

Among the many projects Jones has overseen as chair is the production of a regular TV series on local cable access and a podcast called “Ability Assistance,” which highlights nonprofits and government agencies that offer services to the disabled community. 

She received her B.A. degree in political science in 1993 from American University in Washington, D.C., and her J.D. degree with a concentration in public policy in 1996 from the Massachusetts School of Law in Andover.


Tech Advisors, a Medfield-based technology solution provider for small to mid-sized businesses founded by CPAs and specializing in providing IT and technology services to the CPA field, has appointed Jim Young of Sherborn client relations manager.

In this capacity, Young will fill the dual roles of focusing on overall client relations and communication, as well as the cybersecurity and regulatory compliance posture for the company’s client base. In particular, he will work with CEO Konrad Martin and the team in implementing ongoing technical business reviews for each of the firm’s clients, a meeting which thoroughly reviews and evaluates each individual client’s levels of protection while keeping the client base up to speed on all new compliance regulations and requirements.

While relatively new to the IT industry, Young has considerable experience with client relations from his previous career. Prior to joining Tech Advisors, he owned and ran a successful and very client-centric business that provided the consultation, design and installation of fitness centers in private country clubs around the area, according to the company. He worked closely with the club management and memberships, providing exercise and therapy services, along with programming and staffing.

The Lake George, New York, native studied at Champlain College and then Northeastern University.


Covectra, a Westborough-based provider of serialization and track & trace solutions, has appointed Renaat Van den Hooff and Gary Miloscia to its board of directors.

Van den Hooff brings to the Covectra Board of Directors more than 35 years of global operating experience in the healthcare industry, with specific expertise in consumer pharmaceuticals, medical devices and supplies/services for the pharmaceutical industry.

He held various senior leadership positions, as CEO and board member of Temptime Corp. and as president and CEO of a public startup healthcare company that developed and sold innovative wound care products. He had a 20-year career with Johnson & Johnson, serving the latter time there as president of the J&J-Merck consumer pharmaceuticals joint venture worldwide.

Van den Hoof has also been involved for almost 20 years with the National Multiple Sclerosis Foundation where he has served on the board of trustees and chaired multiple strategic committees supporting the CEO.

He holds a bachelor’s degree from VLEKHO and a master’s degree from the Vlerick School of Management at the University of Ghent, Belgium.

Miloscia has more than 22 years of experience in a number of management positions. He currently serves as chief financial officer for Covectra, where he is responsible for all strategic business and financial planning and analysis as well as marketing activities.

Prior to joining Covectra, he held senior level positions at Fidelity Investments, Health Dialog and American Express.

Miloscia holds a bachelor of science degree in finance from Rutgers University and an MBA in finance from the Indiana University Kelley School of Business.


Dyne Therapeutics Inc., a Waltham-based muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, has appointed Dr. Wildon Farwell chief medical officer.

Farwell brings expertise in clinical development and medical affairs in neuromuscular diseases and oligonucleotide therapies, according to Dyne.

Farwell joins Dyne from Biogen Inc., where he was vice president, global head of neuromuscular diseases, medical affairs. During his 10 years at Biogen, he led the development and life cycle management of Spinraza (nusinersen), an oligonucleotide and the first therapy approved for the treatment of spinal muscular atrophy. He also led the late-stage development of tofersen, an investigational oligonucleotide therapy for amyotrophic lateral sclerosis, oversaw clinical and biomarker development for Biogen’s neuromuscular disease portfolio and began his tenure at the company leading pharmacovigilance for multiple product candidates.

Previously, Farwell was an assistant professor in medicine at Harvard Medical School and a physician at Brigham and Women’s Hospital and the VA Boston Healthcare System.

He received his M.D. from the University of Missouri School of Medicine and an MPH in clinical effectiveness from Harvard University School of Public Health.


KnowSeafood, the first direct-to-home online seafood marketplace using blockchain technology to ensure that consumers have complete transparency and traceability for their seafood purchases, recently appointed Michael DiLorenzo of Maynard its first chief marketing officer.

In this newly created position, DiLorenzo will report to CEO Daniel McQuade. DiLorenzo will have global responsibility for the company’s digital marketing, PR/communications, content and social media; SEO, SEM, affiliate marketing, growth marketing channels, and CRM, along with branding and marketing design as the company scales its brand to both consumers and global partners.

DiLorenzo brings extensive marketing expertise to his new role, and is best known for joining the on-demand alcohol delivery service Drizly before its public launch in 2014 and architecting that company’s launch marketing strategy. The success of Drizly during DiLorenzo’s tenure (2014-2016) in seizing the first-mover advantage in the market culminated with the company’s eventual acquisition by Uber for $1.1 billion in 2021.

DiLorenzo is also known for his pioneering work in social media marketing, having created one of the first social media marketing and strategy departments in professional sports during his tenure at the National Hockey League. For that work, he was named to the prestigious “40 Under 40” list by PRWeek Magazine in 2010.

Since 2016, DiLorenzo has served as the CMO at GasBuddy, one of the most widely used travel and navigation apps globally, boasting nearly 100 million lifetime downloads. At GasBuddy, he led the marketing team that launched its popular payment product, Pay with GasBuddy, which has attracted hundreds of thousands of consumer enrollments since its 2017 launch.

KnowSeafood is based in New Bedford.


The New England chapter of the American Diabetes Association (ADA) recently added three new members to the Community Leadership Board: John Downey, chief commercial officer at Glytec; Ed Ludwigson, vice president of management operations at Staples; and Greg Melton, assistant vice president of marketing at SBLI.

At Staples, Ludwigson is responsible for improving the effectiveness of the company’s business to business sales teams. His focus is on accelerating the sales process through the better use of technology, data and teamwork.

Prior to his role leading sales operations, Ludwigson managed the technology sales division for Staples Business Advantage and led several merger integrations.

He earned undergraduate degree at Boston College and MBA at Dartmouth College, Tuck School of Business. He lives in Upton.


AquaBounty Technologies Inc., a land-based aquaculture company, has hired Dennis Bryant as its new director of sales.

In this role, Bryant will oversee company sales initiatives which include all aspects of building and servicing its growing customer partnerships.

Bryant, formerly the managing director for Ocean Quality USA, brings extensive experience in seafood sales to the position. In his role at Ocean Quality, he was responsible for sales, marketing, distribution and financial results for the company’s portfolio of fresh, farmed Atlantic salmon in the U.S. market.

Before that, Bryant was director of program sales for the seafood distributor Buckhead Meat and Seafood of Houston. He also has direct experience in food service, having worked with several restaurant groups.

AquaBounty is based in Maynard.


Allena Pharmaceuticals Inc., a Newton-based, late-stage biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney disorders, has appointed Mark J. Fitzpatrick to its board of directors.

Fitzpatrick brings more than 30 years of operational and financial management experience to Allena. Most recently, he spent six years at Chiasma Inc. where he served initially as chief financial officer and subsequently president and CEO, and played an integral role in securing U.S. Food and Drug Administration approval of Mycapssa for the treatment of acromegaly.

Prior to Chiasma, he served as chief financial officer for several biopharmaceutical companies. In these roles, he raised more than $1.5 billion in both public and private equity and debt financings, and helped negotiate strategic collaborations with both large pharmaceutical companies and commercial contract manufacturers.

Fitzpatrick began his career at Arthur Andersen LLP and holds a B.S. degree in accounting from Boston College.

In conjunction with Fitzpatrick’s appointment, Allena announced that board members Dr. James Topper, managing general partner at Frazier Healthcare and a founding member of the company’s board of directors since 2011, and Dr. Andrew A. F. Hack, a member of the company’s board of directors since 2018, will not stand for re-election at the company’s annual meeting in June.


Danforth Advisors LLC, a life science industry resource for operational accounting, finance support and strategic CFO advisory, has promoted Chris Connors CEO>

The move reflects his nearly two-year tenure as president, during which time the company achieved record growth in revenues and client base as well as the establishment of a scalable infrastructure to support its growing operations and long-term strategy.

Connors joined Danforth in 2019 as the company’s first president, overseeing internal operations and the growth and expansion of the company and its service offerings.

Connors previously spent 15 years in senior leadership positions at Vistaprint, where he was instrumental to the company’s growth from start-up operations to achieving more than $1 billion in revenue. His responsibilities included setting the strategic direction and rolling out of new customer support services, as well as the infrastructure design and personnel needs required for Vistaprint’s operation.

Prior to joining Vistaprint, Connors spent seven years as a senior technical consultant at Envisa and Accenture.

Danforth is based in Waltham.


Formerly the executive director of Waterstone at Wellesley, Kristine Tilton has been named the new vice president of operations for Waterstone Senior Living, with senior living communities currently located throughout Boston and Wellesley and new communities under development in Stamford, Connecticut, and White Plains, New York.

Tilton will now be responsible for the operational oversight of all current and future communities.

Waltham-based EPOCH Senior Living operates the Waterstone at the Circle senior living community in Boston, the award-winning Waterstone at Wellesley independent and assisted living community, and ten Bridges by EPOCH memory care assisted living communities, with several other properties currently under construction.